Find Saquinavir Mesylate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

181 RELATED EXCIPIENT COMPANIES

276EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 149845-06-7, Invirase, Fortovase, Saquinavir mesilate, Saquinavir, mesylate, Ro 31-8959/003
Molecular Formula
C39H54N6O8S
Molecular Weight
766.9  g/mol
InChI Key
IRHXGOXEBNJUSN-YOXDLBRISA-N
FDA UNII
UHB9Z3841A

Saquinavir Mesylate
An HIV protease inhibitor which acts as an analog of an HIV protease cleavage site. It is a highly specific inhibitor of HIV-1 and HIV-2 proteases, and also inhibits CYTOCHROME P-450 CYP3A.
1 2D Structure

Saquinavir Mesylate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide;methanesulfonic acid
2.1.2 InChI
InChI=1S/C38H50N6O5.CH4O3S/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29;1-5(2,3)4/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49);1H3,(H,2,3,4)/t26-,27+,30-,31-,32-,33+;/m0./s1
2.1.3 InChI Key
IRHXGOXEBNJUSN-YOXDLBRISA-N
2.1.4 Canonical SMILES
CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O.CS(=O)(=O)O
2.1.5 Isomeric SMILES
CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O.CS(=O)(=O)O
2.2 Other Identifiers
2.2.1 UNII
UHB9Z3841A
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Invirase

2. Monomethanesulfonate, Saquinavir

3. Ro 31 8959

4. Ro 31-8959

5. Ro 318959

6. Saquinavir

7. Saquinavir Monomethanesulfonate

8. Saquinivir

2.3.2 Depositor-Supplied Synonyms

1. 149845-06-7

2. Invirase

3. Fortovase

4. Saquinavir Mesilate

5. Saquinavir, Mesylate

6. Ro 31-8959/003

7. Saquinavir Methanesulfonate Salt

8. Uhb9z3841a

9. Butanediamide, N1-[(1s,2r)-3-[(3s,4as,8as)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1h)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-, (2s)-, Methanesulfonate (1:1)

10. Chebi:32121

11. (2s)-n-[(2s,3r)-4-[(3s,4as,8as)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1h-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide;methanesulfonic Acid

12. (s)-n1-((2s,3r)-4-((3s,4as,8as)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1h)-yl)-3-hydroxy-1-phenylbutan-2-yl)-2-(quinoline-2-carboxamido)succinamide Methanesulfonate

13. Ncgc00091469-01

14. Ro-318959003

15. Dsstox_cid_3835

16. Ro-31-8959/003

17. Saquinavir Mesilate (jan)

18. Dsstox_rid_77202

19. Dsstox_gsid_23835

20. Saquinavir Mesilate [jan]

21. Saquinavir Mesylate [usan]

22. Saquinavir Monomethanesulfonate Salt

23. Unii-uhb9z3841a

24. Saquinavir Mesylate [usan:usp]

25. Invirase (tn)

26. N1-{(1s,2r)-1-benzyl-3-[(3s,4as,8as)-3-[(tert-butylamino)carbonyl]octahydroisoquinolin-2(1h)-yl]-2-hydroxypropyl}-n2-(quinolin-2-ylcarbonyl)-l-aspartamide Methanesulfonate (salt)

27. Cas-149845-06-7

28. Saquinavir Mesylate (aids Initiative)

29. Sqv

30. Saquinavir Mesylate (usp)

31. Saquinavir Mesylate- Bio-x

32. Schembl42352

33. (s)-n-((alphas)-alpha-((1r)-2-((3s,4as,8as)-3-(tert-butylcarbamoyl)octahydro-2(1h)-isoquinolyl)-1-hydroxyethyl)phenethyl)-2-quinaldamidosuccinamide Monomethanesulfonate (salt)

34. Mls001401395

35. Chembl282042

36. Dtxsid9023835

37. Hms1571o10

38. Hms2051d04

39. Hms2098o10

40. Hms2231c15

41. Hms3715o10

42. Saquinavir Mesylate [vandf]

43. Saquinavir Mesilate [mart.]

44. Tox21_111137

45. Tox21_202533

46. Saquinavir Mesilate [who-dd]

47. Saquinavir Mesilate [who-ip]

48. Saquinavir Mesylate [usp-rs]

49. Akos015962362

50. Ac-1333

51. Ccg-100992

52. Ks-1110

53. Nc00242

54. Ncgc00260082-01

55. Saquinavir Mesylate [orange Book]

56. (2s)-n1[(1s,2r)-3-[(3s,4as,8as)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2-(1h)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]butanediamide Mesylate

57. Bs164392

58. Butanediamide, N(sup 1)-(3-(3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1h)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (3s-(2(1r*(r*),2s*),3alpha,4abeta,8abeta))-, Monomethanesulfonate (salt)

59. Butanediamide, N1-((1s,2r)-3-((3s,4as,8as)-3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1h)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (2s)-, Monomethanesulfonate (salt)

60. R-56

61. Saquinavir Mesilate [ep Monograph]

62. Saquinavir Mesylate [usp Impurity]

63. Smr000469290

64. Saquinavir Mesylate [usp Monograph]

65. Saquinavir Methanesulfonate Salt [mi]

66. Ro-31-8959-003

67. Saquinavir Mesylate, >=98% (hplc), Powder

68. D01160

69. 845s067

70. Sr-01000763454

71. J-008634

72. Sr-01000763454-4

73. Q27114794

74. Saquinavir Mesilate, European Pharmacopoeia (ep) Reference Standard

75. Saquinavir Mesylate, United States Pharmacopeia (usp) Reference Standard

76. Saquinavir For System Suitability, European Pharmacopoeia (ep) Reference Standard

77. (2s)-n1-[(1s,2r)-3-[(3s,4as,8as)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1h)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]butanediamide Methanesulfonate

78. (s)-n-((.alpha.s)-.alpha.-((1r)-2-((3s,4as,8as)-3-(tert-butylcarbamoyl)octahydro-2(1h)-isoquinolyl)-1-hydroxyethyl)phenethyl)-2-quinaldamidosuccinamide Monomethanesulfonate

79. (s)-n-((.alpha.s)-.alpha.-((1r)-2-((3s,4as,8as)-3-(tert-butylcarbamoyl)octahydro-2(1h)-isoquinolyl)-1-hydroxyethyl)phenethyl)-2-quinaldamidosuccinamide Monomethanesulphonate

80. Butanediamide, N(sup 1)-(3-(3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1h)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (3s-(2(1r*(r*),2s*),3.alpha.,4a.beta.,8a.beta.))-, Monomethanesulfonate

81. Butanediamide, N(sup 1)-(3-(3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1h)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (3s-(2(1r*(r*),2s*),3.alpha.,4a.beta.,8a.beta.))-, Monomethanesulphonate

82. N-t-butyl-decahydro-2-[2(r)-hydroxy-4-phenyl-3(s)-[[n-(2-quinolylcarbonyl)-l-asparaginyl]amino]butyl]-(4as,8as)-isoquinoline-3(s)-carboxamide Methanesulphonate

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 766.9 g/mol
Molecular Formula C39H54N6O8S
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count10
Rotatable Bond Count13
Exact Mass766.37238388 g/mol
Monoisotopic Mass766.37238388 g/mol
Topological Polar Surface Area230 Ų
Heavy Atom Count54
Formal Charge0
Complexity1230
Isotope Atom Count0
Defined Atom Stereocenter Count6
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameInvirase
PubMed HealthSaquinavir (By mouth)
Drug ClassesAntiretroviral Agent
Drug LabelINVIRASE brand of saquinavir mesylate is an inhibitor of the human immunodeficiency virus (HIV) protease. INVIRASE is available as light brown and green, opaque hard gelatin capsules for oral administration in a 200-mg strength (as saquinavir free ba...
Active IngredientSaquinavir mesylate
Dosage FormTablet; Capsule
RouteOral
Strengtheq 500mg base; eq 200mg base
Market StatusPrescription
CompanyHoffman La Roche; Hoffmann La Roche

2 of 2  
Drug NameInvirase
PubMed HealthSaquinavir (By mouth)
Drug ClassesAntiretroviral Agent
Drug LabelINVIRASE brand of saquinavir mesylate is an inhibitor of the human immunodeficiency virus (HIV) protease. INVIRASE is available as light brown and green, opaque hard gelatin capsules for oral administration in a 200-mg strength (as saquinavir free ba...
Active IngredientSaquinavir mesylate
Dosage FormTablet; Capsule
RouteOral
Strengtheq 500mg base; eq 200mg base
Market StatusPrescription
CompanyHoffman La Roche; Hoffmann La Roche

4.2 Drug Indication

Invirase is indicated for the treatment of HIV-1-infected adult patients. Invirase should only be given in combination with ritonavir and other antiretroviral medicinal products.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Cytochrome P-450 CYP3A Inhibitors

Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP3A. (See all compounds classified as Cytochrome P-450 CYP3A Inhibitors.)


HIV Protease Inhibitors

Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. (See all compounds classified as HIV Protease Inhibitors.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
HIV Protease Inhibitors [MoA]; Protease Inhibitor [EPC]; Cytochrome P450 3A Inhibitors [MoA]
5.3 ATC Code

J05AE01


Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Direct Compression

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Controlled & Modified Release

read-more
read-more

Granulation

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Lubricants & Glidants

read-more
read-more

Empty Capsules

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Coloring Agents

read-more
read-more

Vegetarian Capsules

read-more
read-more

Taste Masking

read-more
read-more

API Stability Enhancers

read-more
read-more

Rheology Modifiers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Solubilizers

read-more
read-more

Emulsifying Agents

read-more
read-more

Parenteral

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Saquinavir Mesylate Manufacturers

A Saquinavir Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Saquinavir Mesylate, including repackagers and relabelers. The FDA regulates Saquinavir Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Saquinavir Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Saquinavir Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Saquinavir Mesylate Suppliers

A Saquinavir Mesylate supplier is an individual or a company that provides Saquinavir Mesylate active pharmaceutical ingredient (API) or Saquinavir Mesylate finished formulations upon request. The Saquinavir Mesylate suppliers may include Saquinavir Mesylate API manufacturers, exporters, distributors and traders.

click here to find a list of Saquinavir Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Saquinavir Mesylate USDMF

A Saquinavir Mesylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Saquinavir Mesylate active pharmaceutical ingredient (API) in detail. Different forms of Saquinavir Mesylate DMFs exist exist since differing nations have different regulations, such as Saquinavir Mesylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Saquinavir Mesylate DMF submitted to regulatory agencies in the US is known as a USDMF. Saquinavir Mesylate USDMF includes data on Saquinavir Mesylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Saquinavir Mesylate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Saquinavir Mesylate suppliers with USDMF on PharmaCompass.

Saquinavir Mesylate WC

A Saquinavir Mesylate written confirmation (Saquinavir Mesylate WC) is an official document issued by a regulatory agency to a Saquinavir Mesylate manufacturer, verifying that the manufacturing facility of a Saquinavir Mesylate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Saquinavir Mesylate APIs or Saquinavir Mesylate finished pharmaceutical products to another nation, regulatory agencies frequently require a Saquinavir Mesylate WC (written confirmation) as part of the regulatory process.

click here to find a list of Saquinavir Mesylate suppliers with Written Confirmation (WC) on PharmaCompass.

Saquinavir Mesylate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Saquinavir Mesylate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Saquinavir Mesylate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Saquinavir Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Saquinavir Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Saquinavir Mesylate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Saquinavir Mesylate suppliers with NDC on PharmaCompass.

Saquinavir Mesylate GMP

Saquinavir Mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Saquinavir Mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Saquinavir Mesylate GMP manufacturer or Saquinavir Mesylate GMP API supplier for your needs.

Saquinavir Mesylate CoA

A Saquinavir Mesylate CoA (Certificate of Analysis) is a formal document that attests to Saquinavir Mesylate's compliance with Saquinavir Mesylate specifications and serves as a tool for batch-level quality control.

Saquinavir Mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Saquinavir Mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Saquinavir Mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Saquinavir Mesylate EP), Saquinavir Mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Saquinavir Mesylate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty